A regulatory affairs team is preparing a risk-based submission strategy for a novel medical device. Which factor MOST influences the choice between a 510(k) and a PMA pathway?
-
A
Device manufacturing location
-
B
The level of risk the device poses to patients
-
C
The number of intended users
-
D
Market size of the intended indication